Updated Jul 16, 2026
Smith Mary L. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.43M.
Mary L. Smith is identified in SEC insider filings as affiliated with PTC Therapeutics, Inc. as of July 13, 2026. Beyond this affiliation, publicly available biographical details are not provided in the context given. She does not appear to be a widely public figure based on the information provided.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | PTCT | PTC THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 5.8K | $90.00 | $525K |
| 2026-07-13 | PTCT | PTC THERAPEUTICS, INC. | M — Option exercise [10b5-1] | 5.8K | $42.95 | $251K |
| 2026-07-13 | PTCT | PTC THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 10.0K | $90.00 | $900K |
| 2026-07-13 | PTCT | PTC THERAPEUTICS, INC. | M — Option exercise [10b5-1] | 10.0K | $42.95 | $430K |
Mary L. Smith is identified in SEC insider filings as affiliated with PTC Therapeutics, Inc. as of July 13, 2026. Beyond this affiliation, publicly available biographical details are not provided in the context given. She does not appear to be a widely public figure based on the information provided.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.43M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Smith Mary L. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.